As­traZeneca dou­bles down on COPD aware­ness ef­forts dur­ing na­tion­al aware­ness month

More than half of peo­ple liv­ing with chron­ic ob­struc­tive pul­monary dis­ease in the US are un­di­ag­nosed. It’s not a brand new prob­lem, but it’s one As­traZeneca is shin­ing a light on with mar­ket­ing and aware­ness ef­forts dur­ing No­vem­ber’s Na­tion­al COPD Aware­ness Month.

AZ physi­cian part­ner nd lead­ing pul­mo­nolo­gist MeiLan Han is lend­ing her ex­per­tise to its ef­fort and speak­ing out about the chal­lenges and stig­ma of COPD.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER